Related Experiment Video
Updated: Jun 25, 2026
08:49
Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
[Gene expression profiling in lung cancer. Experimental research and clinical application]
R Kuner1, H Hoffmann, H Sültmann
1Molekulare Genomanalyse, Deutsches Krebsforschungszentrum, Heidelberg. r.kuner@dkfz.de
Deutsche Medizinische Wochenschrift (1946)
|March 5, 2009
Summary
Microarray technology analyzes global gene expression, revealing transcriptional changes in lung cancer. This aids in diagnosis, prognosis, and identifying new drug targets for improved patient outcomes.
Area of Science:
- Genomics
- Molecular Biology
- Oncology
Context:
- Microarray technology enables simultaneous global gene expression analysis in cells and tissues.
- Significant transcriptional alterations in tumor diseases are identified using microarrays.
- Gene expression profiles derived from microarrays are crucial in cancer research.
Purpose:
- To review the current state-of-the-art of microarray analyses in lung cancer.
- To discuss the limitations and translational applications of microarray data.
- To outline future directions for microarray technology in lung cancer research.
Summary:
- Microarray technology provides a comprehensive view of gene expression patterns.
- These patterns offer insights into tumor biology, aiding in diagnosis and prognosis.
- The review covers technological advancements, challenges, and clinical relevance of microarrays in lung cancer.
Impact:
- Facilitates the prediction of diagnosis, prognosis, and therapeutic outcomes in lung cancer patients.
- Enables the identification of novel molecular targets for drug development.
- Advances our understanding of lung cancer pathogenesis and personalized medicine strategies.
